US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Park Hotels & Resorts Inc.

15.21

+0.01000.07%

Volume:4.56M

Turnover:69.29M

Market Cap:3.06B

PE:-18.40

High:15.36

Open:15.35

Low:15.00

Close:15.20

52wk High:16.20

52wk Low:9.84

Shares:201.40M

Float Shares:195.63M

Volume Ratio:1.17

T/O Rate:2.33%

Dividend:1

Dividend Rate:6.57%

EPS(TTM):-0.8265

EPS(LYR):-1.4300

ROE:-4.86%

ROA:2.75%

PB:0.99

PE(LYR):-10.64

Loading ...

Overview Company News Filings

Cullinan Therapeutics Announces First Patient Dosed in Planned Registrational Phase 2 Study of CLN-049 in Relapsed/Refractory Acute Myeloid Leukemia

Hilton Names Jeff Moore Executive Vice President, Chief Technology Officer

Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly

Climb Bio to Present New Data at American Society of Nephrology (ASN) Kidney Week 2026 for CLYM116 and Budoprutug

Park Hotels & Resorts (PK) Could Be 25% Undervalued On Its Debt Refinance

Simply Wall St.

Agomab Reports Positive Topline Data from STENOVA Open-Label Extension Study of Ontunisertib in Fibrostenosing Crohn's Disease

Park Hotels & Resorts Repays USD 1.28 Billion Hilton Hawaiian Village Mortgage Loan

Park Hotels & Resorts - Extends Weighted-Average Debt Maturity to 3.1 Years; Less than 11% Debt Matures Through 2027

THOMSON REUTERS

Park Hotels & Resorts - Repayment Funded by $700 Mln Bonnet Creek Mortgage and $600 Mln Term Loan Facility

THOMSON REUTERS

Press Release: Avacta Group Plc: Interim Results for the Six Months to June 30, 2026, and Business Update

Propanc Biopharma Provides Corporate Update & Year-End June 30, 2025-26, Financial Results

Nasus Pharma Announces Enrollment and Dosing of First Patient in Phase 1 Study of NS003 Intranasal Formulation of Ondansetron

M Core Acquires Newcastle Leisure Complex the Gate

Park Hotels & Resorts Inc : Raymond James Raises to Strong Buy from Market Perform

THOMSON REUTERS

Avacta Group plc: The FOCUS-01 Clinical Trial Design and Preclinical Data Further Demonstrate the Potential of AVA6103 at AACR Conference on Pancreatic Cancer

Avacta Achieves Clinical Proof of Mechanism for the Next Generation of pre|CISION® Medicines with AVA6103 (FAP-Exd) in the Phase 1 FOCUS-01 Trial

Truist Financial Sticks to Its Hold Rating for Park Hotels & Resorts (PK)

Agomab Announces Positive Phase 1 Results for AGMB-447 in Patients with Idiopathic Pulmonary Fibrosis and Design of Phase 2 INSPIRIA Study

Sionna Therapeutics Announces Plans to Advance SION-451 + SION-2222 Dual Combination into Phase 2a Proof-of-Concept Trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/PK/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PK\",,,,,undefined,":{"symbol":"PK","market":"US","secType":"STK","nameCN":"Park Hotels & Resorts Inc.","latestPrice":15.21,"timestamp":1791489600000,"preClose":15.2,"halted":0,"volume":4555437,"delay":0,"changeRate":0.0006578947368422081,"floatShares":195633448,"shares":201398439,"eps":-0.826466,"marketStatus":"Pre-Mkt","change":0.01,"latestTime":"10-09 08:16:47 EDT","open":15.35,"high":15.36,"low":15,"amount":69288547.53864901,"amplitude":0.023684,"askPrice":17.25,"askSize":100,"bidPrice":15.09,"bidSize":165,"shortable":3,"etf":0,"ttmEps":-0.826466,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791552600000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":15.21,"dividendRate":0.065746,"postHourTrading":{"tag":"盘后","latestPrice":15.21,"preClose":15.21,"latestTime":"19:30 EDT","volume":243124,"amount":3697920.0904,"timestamp":1791502204036,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.1687354592910533,"impliedVol":0.3795,"impliedVolPercentile":0.316},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PK\",,,,,undefined,":{"symbol":"PK","floatShares":195633448,"roa":"2.75%","roe":"-4.86%","lyrEps":-1.43,"volumeRatio":1.1687354592910533,"shares":201398439,"dividePrice":1,"high":15.36,"amplitude":0.023684,"preClose":15.2,"low":15,"week52Low":9.84,"pbRate":"0.99","psRate":"1.20","week52High":16.2,"institutionHeld":0,"latestPrice":15.21,"committee":0.245283,"eps":-0.826466,"divideRate":0.065746,"volume":4555437,"delay":0,"ttmEps":-0.826466,"open":15.35,"prevYearClose":10.46,"prevWeekClose":15.53,"prevMonthClose":15.42,"prevQuarterClose":15.42,"fiveDayClose":15.42,"twentyDayClose":15.32,"sixtyDayClose":14.55,"earningDate":1793721600000,"earningTime":"盘后","dividendPayoutRate":1.373460620431404,"dividendFrequency":"Q","dividendGrowthYears":0,"dividendGrowthRate":-0.28571428571428564,"fiveYearAvgDividendRate":0.07559574201047665},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PK\",params:#limit:5,,,undefined,":[{"date":"2026-11-04","symbol":"PK","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2026/09","expectedEps":0.34,"defaultRemindTime":1793826000000,"name":null,"time":"Post-Mkt","dateTimestamp":1793768400000,"actualEps":null},{"date":"2026-09-30","symbol":"PK","amount":0.25,"announcedDate":"2026-07-31","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-30","defaultRemindTime":1790775000000,"name":"Park Hotels & Resorts Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-15","payableDate":"2026-09-30","currency":"USD","dateTimestamp":1790740800000,"payDate":"2026-10-15"},{"market":"US","date":"2026-08-06","symbol":"PK","fiscalQuarterEnding":"2026/06","expectedEps":0.57,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":0.7},{"date":"2026-06-30","symbol":"PK","amount":0.25,"announcedDate":"2026-04-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-30","defaultRemindTime":1782826200000,"name":"Park Hotels & Resorts Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-15","payableDate":"2026-06-30","currency":"USD","dateTimestamp":1782792000000,"payDate":"2026-07-15"},{"market":"US","date":"2026-04-30","symbol":"PK","fiscalQuarterEnding":"2026/03","expectedEps":0.38,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1777521600000,"reportTimeType":"post","actualEps":0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PK\",market:\"US\",,,undefined,":[{"executeDate":"2017-03-29","recordDate":"2017-03-31","paymentDate":"2017-04-17","value":0.43,"currency":"USD"},{"executeDate":"2017-06-28","recordDate":"2017-06-30","paymentDate":"2017-07-17","value":0.43,"currency":"USD"},{"executeDate":"2017-09-28","recordDate":"2017-09-29","paymentDate":"2017-10-16","value":0.43,"currency":"USD"},{"executeDate":"2017-12-28","recordDate":"2017-12-29","paymentDate":"2018-01-16","value":0.55,"currency":"USD"},{"executeDate":"2018-03-28","recordDate":"2018-03-30","paymentDate":"2018-04-16","value":0.43,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PK\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1765,"buy":0.1176,"hold":0.5882,"sell":0.1176,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.5882,"analysts":17,"updateTime":1790654400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PK\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PK","date":"2026-10-08","current":-18.403661,"percent":0.23888,"low":-196.066894,"twenty":-46.400028,"median":-6.205152,"eighty":17.858097,"high":55.399897,"avg":-11.707968,"sd":52.712603,"marketCap":3060342616},"quantilePoints":[{"date":"2021-10-15","current":-5.659254,"twenty":-3.625758,"median":12.578404,"eighty":24.655885,"marketCap":4521744152},{"date":"2021-10-22","current":-5.505341,"twenty":-3.649856,"median":12.569511,"eighty":24.645785,"marketCap":4398767847},{"date":"2021-10-29","current":-5.484622,"twenty":-3.670075,"median":12.545167,"eighty":24.625583,"marketCap":4382213344},{"date":"2021-11-05","current":-8.201051,"twenty":-3.681985,"median":12.518997,"eighty":24.605382,"marketCap":4994440260},{"date":"2021-11-12","current":-7.56811,"twenty":-3.701263,"median":12.505104,"eighty":24.575079,"marketCap":4608979198},{"date":"2021-11-19","current":-7.339009,"twenty":-3.720957,"median":12.481428,"eighty":24.44377,"marketCap":4469456483},{"date":"2021-11-26","current":-6.989532,"twenty":-3.729965,"median":12.465978,"eighty":24.427609,"marketCap":4256625222},{"date":"2021-12-03","current":-6.488616,"twenty":-3.750955,"median":12.411262,"eighty":24.415488,"marketCap":3951567081},{"date":"2021-12-10","current":-7.129323,"twenty":-3.770233,"median":12.390156,"eighty":24.397368,"marketCap":4341757726},{"date":"2021-12-17","current":-6.752665,"twenty":-3.792938,"median":12.369502,"eighty":24.247831,"marketCap":4112372922},{"date":"2021-12-23","current":-7.490449,"twenty":-3.83227,"median":12.348324,"eighty":24.162969,"marketCap":4561683362},{"date":"2021-12-31","current":-7.331243,"twenty":-3.873903,"median":12.336915,"eighty":24.124587,"marketCap":4464726899},{"date":"2022-01-07","current":-7.692369,"twenty":-3.888468,"median":12.314228,"eighty":24.072063,"marketCap":4684652535},{"date":"2022-01-14","current":-7.548695,"twenty":-3.917478,"median":12.283673,"eighty":24.03368,"marketCap":4597155239},{"date":"2022-01-21","current":-7.032246,"twenty":-3.996222,"median":12.241172,"eighty":24.02964,"marketCap":4282637931},{"date":"2022-01-28","current":-6.803145,"twenty":-4.087905,"median":12.214275,"eighty":24.013479,"marketCap":4143115216},{"date":"2022-02-04","current":-7.051662,"twenty":-4.210886,"median":12.177189,"eighty":23.964995,"marketCap":4294461890},{"date":"2022-02-11","current":-7.339009,"twenty":-4.305038,"median":12.115818,"eighty":23.924593,"marketCap":4469456483},{"date":"2022-02-18","current":-9.97933,"twenty":-4.379327,"median":12.077002,"eighty":23.906411,"marketCap":4580512556},{"date":"2022-02-25","current":-9.762948,"twenty":-4.434604,"median":12.034907,"eighty":23.88419,"marketCap":4481193234},{"date":"2022-03-04","current":-9.294121,"twenty":-4.477502,"median":11.989722,"eighty":23.857928,"marketCap":4266001369},{"date":"2022-03-11","current":-9.515655,"twenty":-4.530065,"median":11.874947,"eighty":23.585208,"marketCap":4367685437},{"date":"2022-03-18","current":-9.793479,"twenty":-4.62021,"median":11.802039,"eighty":23.304408,"marketCap":4495206674},{"date":"2022-03-25","current":-9.839796,"twenty":-4.668569,"median":11.613959,"eighty":23.136735,"marketCap":4516466191},{"date":"2022-04-01","current":-10.045649,"twenty":-4.723283,"median":11.244693,"eighty":22.801391,"marketCap":4610952931},{"date":"2022-04-08","current":-8.795089,"twenty":-4.748358,"median":11.177001,"eighty":22.577155,"marketCap":4036945983},{"date":"2022-04-14","current":-9.860381,"twenty":-4.774334,"median":11.132722,"eighty":22.280194,"marketCap":4525914865},{"date":"2022-04-22","current":-9.999332,"twenty":-4.831692,"median":11.002063,"eighty":21.938028,"marketCap":4589693414},{"date":"2022-04-29","current":-10.143429,"twenty":-4.933265,"median":10.846102,"eighty":20.988446,"marketCap":4655834133},{"date":"2022-05-06","current":-13.808923,"twenty":-5.010567,"median":10.72108,"eighty":20.329014,"marketCap":4501708843},{"date":"2022-05-13","current":-13.178967,"twenty":-5.093895,"median":7.386072,"eighty":20.146479,"marketCap":4296343172},{"date":"2022-05-20","current":-11.861786,"twenty":-5.147058,"median":6.828781,"eighty":19.994366,"marketCap":3866942225},{"date":"2022-05-27","current":-13.143174,"twenty":-5.175677,"median":6.45202,"eighty":19.781409,"marketCap":4284674668},{"date":"2022-06-03","current":-13.207601,"twenty":-5.20439,"median":6.373529,"eighty":19.661408,"marketCap":4305677976},{"date":"2022-06-10","current":-12.055068,"twenty":-5.217352,"median":6.1773,"eighty":18.57907,"marketCap":3929952147},{"date":"2022-06-17","current":-10.229627,"twenty":-5.287145,"median":5.839785,"eighty":18.013987,"marketCap":3334858443},{"date":"2022-06-24","current":-10.1652,"twenty":-5.323251,"median":5.651405,"eighty":17.603643,"marketCap":3313855136},{"date":"2022-07-01","current":-9.70705,"twenty":-5.360954,"median":5.101963,"eighty":17.208917,"marketCap":3164498284},{"date":"2022-07-08","current":-9.85738,"twenty":-5.388567,"median":3.861793,"eighty":17.068349,"marketCap":3213506001},{"date":"2022-07-15","current":-9.921808,"twenty":-5.409668,"median":2.45556,"eighty":16.809931,"marketCap":3234509308},{"date":"2022-07-22","current":-10.487336,"twenty":-5.439477,"median":2.417283,"eighty":16.594109,"marketCap":3418871672},{"date":"2022-07-29","current":-11.160244,"twenty":-5.472783,"median":2.404801,"eighty":15.354106,"marketCap":3638239547},{"date":"2022-08-05","current":-56.398031,"twenty":-5.505341,"median":2.387327,"eighty":15.148576,"marketCap":3383881882},{"date":"2022-08-12","current":-60.145409,"twenty":-5.52902,"median":2.299955,"eighty":15.006602,"marketCap":3608724532},{"date":"2022-08-19","current":-55.873399,"twenty":-5.552107,"median":2.257518,"eighty":14.887345,"marketCap":3352403911},{"date":"2022-08-26","current":-53.287708,"twenty":-5.563474,"median":2.212781,"eighty":14.845845,"marketCap":3197262483},{"date":"2022-09-02","current":-52.238442,"twenty":-5.614856,"median":2.207821,"eighty":14.818112,"marketCap":3134306541},{"date":"2022-09-09","current":-54.786659,"twenty":-5.644455,"median":2.197209,"eighty":14.800268,"marketCap":3287199543},{"date":"2022-09-16","current":-52.051073,"twenty":-5.663398,"median":2.187137,"eighty":14.752289,"marketCap":3123064408},{"date":"2022-09-23","current":-44.593792,"twenty":-5.688853,"median":2.168482,"eighty":14.705619,"marketCap":2675627535},{"date":"2022-09-30","current":-42.195471,"twenty":-5.714833,"median":2.125089,"eighty":14.651669,"marketCap":2531728239},{"date":"2022-10-07","current":-43.582,"twenty":-5.729107,"median":2.082185,"eighty":14.616649,"marketCap":2614920019},{"date":"2022-10-14","current":-44.219054,"twenty":-5.777649,"median":2.070313,"eighty":14.587307,"marketCap":2653143270},{"date":"2022-10-21","current":-47.216957,"twenty":-5.925642,"median":2.05882,"eighty":14.530184,"marketCap":2833017390},{"date":"2022-10-28","current":-48.828329,"twenty":-6.246611,"median":2.029326,"eighty":14.486979,"marketCap":2929699729},{"date":"2022-11-04","current":43.862859,"twenty":-6.452657,"median":2.015912,"eighty":14.434922,"marketCap":2675634425},{"date":"2022-11-11","current":47.03278,"twenty":-6.452657,"median":2.015912,"eighty":14.434922,"marketCap":2868999602},{"date":"2022-11-18","current":45.005505,"twenty":-6.452657,"median":2.015912,"eighty":14.434922,"marketCap":2745335826},{"date":"2022-11-25","current":45.742696,"twenty":-6.452657,"median":2.015912,"eighty":14.434922,"marketCap":2790304471},{"date":"2022-12-02","current":46.553606,"twenty":-6.452657,"median":2.015912,"eighty":14.434922,"marketCap":2839769982},{"date":"2022-12-09","current":45.41096,"twenty":-6.452657,"median":2.015912,"eighty":14.434922,"marketCap":2770068581},{"date":"2022-12-16","current":44.342034,"twenty":-6.452657,"median":2.015912,"eighty":14.434922,"marketCap":2704864044},{"date":"2022-12-23","current":42.941371,"twenty":-6.452657,"median":2.015912,"eighty":14.434922,"marketCap":2619423617},{"date":"2022-12-30","current":43.457404,"twenty":-6.452657,"median":2.015912,"eighty":14.434922,"marketCap":2650901669},{"date":"2023-01-06","current":44.010298,"twenty":-6.452657,"median":2.015912,"eighty":14.499284,"marketCap":2684628154},{"date":"2023-01-13","current":46.332449,"twenty":-6.452657,"median":2.015912,"eighty":14.544715,"marketCap":2826279388},{"date":"2023-01-20","current":47.585674,"twenty":-6.452657,"median":2.015912,"eighty":14.591155,"marketCap":2902726086},{"date":"2023-01-27","current":53.188324,"twenty":-6.452657,"median":2.015912,"eighty":14.629303,"marketCap":3244487794},{"date":"2023-02-03","current":54.478409,"twenty":-6.452657,"median":2.015912,"eighty":14.659241,"marketCap":3323182924},{"date":"2023-02-10","current":52.598572,"twenty":-6.452657,"median":2.015912,"eighty":14.710351,"marketCap":3208512877},{"date":"2023-02-17","current":50.681875,"twenty":-6.452657,"median":2.015912,"eighty":14.776825,"marketCap":3091594398},{"date":"2023-02-24","current":19.081678,"twenty":-6.452657,"median":2.015912,"eighty":14.800268,"marketCap":3091231855},{"date":"2023-03-03","current":19.2873,"twenty":-6.452657,"median":2.020509,"eighty":14.820409,"marketCap":3124542543},{"date":"2023-03-10","current":17.080295,"twenty":-6.452657,"median":2.020509,"eighty":14.858004,"marketCap":2767007824},{"date":"2023-03-17","current":15.80726,"twenty":-6.452657,"median":2.020509,"eighty":14.898703,"marketCap":2560776060},{"date":"2023-03-24","current":15.423721,"twenty":-6.452657,"median":2.034301,"eighty":15.020423,"marketCap":2498642845},{"date":"2023-03-31","current":16.930479,"twenty":-6.449731,"median":2.061884,"eighty":15.148576,"marketCap":2742737617},{"date":"2023-04-06","current":16.355172,"twenty":-6.449731,"median":2.08027,"eighty":15.339767,"marketCap":2649537795},{"date":"2023-04-14","current":16.231891,"twenty":-6.452657,"median":2.187137,"eighty":15.656584,"marketCap":2629566405},{"date":"2023-04-21","current":16.1771,"twenty":-6.452657,"median":2.20399,"eighty":16.160663,"marketCap":2620690231},{"date":"2023-04-28","current":15.916842,"twenty":-6.452657,"median":3.861793,"eighty":16.193538,"marketCap":2578528407},{"date":"2023-05-05","current":10.781494,"twenty":-6.452657,"median":4.795845,"eighty":16.193538,"marketCap":2716936387},{"date":"2023-05-12","current":11.431806,"twenty":-6.452657,"median":4.795845,"eighty":16.193538,"marketCap":2880815089},{"date":"2023-05-19","current":11.705622,"twenty":-6.452657,"median":4.795845,"eighty":16.193538,"marketCap":2949816648},{"date":"2023-05-26","current":11.13232,"twenty":-6.452657,"median":4.795845,"eighty":16.193538,"marketCap":2805344634},{"date":"2023-06-02","current":11.115206,"twenty":-6.452657,"median":4.795845,"eighty":16.193538,"marketCap":2801032037},{"date":"2023-06-09","current":12.184799,"twenty":-6.452657,"median":4.795845,"eighty":16.193538,"marketCap":3070569377},{"date":"2023-06-16","current":11.243558,"twenty":-6.452657,"median":4.795845,"eighty":16.193538,"marketCap":2833376518},{"date":"2023-06-23","current":10.71304,"twenty":-6.455582,"median":4.787996,"eighty":16.201756,"marketCap":2699685997},{"date":"2023-06-30","current":10.926958,"twenty":-6.458508,"median":4.780147,"eighty":16.209975,"marketCap":2753593465},{"date":"2023-07-07","current":11.226444,"twenty":-6.458508,"median":4.780147,"eighty":16.209975,"marketCap":2829063920},{"date":"2023-07-14","current":11.799746,"twenty":-6.458508,"median":4.780147,"eighty":16.209975,"marketCap":2973535934},{"date":"2023-07-21","current":11.260671,"twenty":-6.458508,"median":4.780147,"eighty":16.209975,"marketCap":2837689115},{"date":"2023-07-28","current":10.76438,"twenty":-6.458508,"median":4.780147,"eighty":16.209975,"marketCap":2712623789},{"date":"2023-08-04","current":-57.485197,"twenty":-6.501042,"median":3.861793,"eighty":16.209975,"marketCap":2759289480},{"date":"2023-08-11","current":-60.090736,"twenty":-6.750335,"median":-2.450979,"eighty":16.209975,"marketCap":2884355344},{"date":"2023-08-18","current":-56.854736,"twenty":-6.930509,"median":-2.566048,"eighty":16.209975,"marketCap":2729027307},{"date":"2023-08-25","current":-56.854736,"twenty":-7.00324,"median":-2.678241,"eighty":16.209975,"marketCap":2729027307},{"date":"2023-08-31","current":-58.203069,"twenty":-7.047778,"median":-2.730022,"eighty":16.209975,"marketCap":2793747322},{"date":"2023-09-08","current":-56.225513,"twenty":-7.135536,"median":-2.76742,"eighty":16.220933,"marketCap":2698824633},{"date":"2023-09-13","current":-59.641292,"twenty":-7.238826,"median":-2.81236,"eighty":16.220933,"marketCap":2862782005},{"date":"2023-09-20","current":-56.49518,"twenty":-7.292412,"median":-2.856599,"eighty":16.226412,"marketCap":2711768636},{"date":"2023-09-29","current":-56.270458,"twenty":-7.33179,"median":-2.859478,"eighty":16.256547,"marketCap":2700981967},{"date":"2023-10-06","current":-54.068179,"twenty":-7.350658,"median":-2.872421,"eighty":16.256547,"marketCap":2595272609},{"date":"2023-10-13","current":-54.023235,"twenty":-7.41434,"median":-2.928517,"eighty":16.256547,"marketCap":2593115275},{"date":"2023-10-20","current":-52.944568,"twenty":-7.474917,"median":-3.004751,"eighty":16.256547,"marketCap":2541339263},{"date":"2023-10-23","current":-52.405235,"twenty":-7.491226,"median":-3.007627,"eighty":16.256547,"marketCap":2515451257},{"date":"2023-11-03","current":-48.333767,"twenty":-7.537046,"median":-3.046463,"eighty":16.355172,"marketCap":2706690937},{"date":"2023-11-10","current":-48.821216,"twenty":-7.614707,"median":-3.102759,"eighty":16.355172,"marketCap":2733988086},{"date":"2023-11-17","current":-52.758411,"twenty":-7.692369,"median":-3.147149,"eighty":16.355172,"marketCap":2954470996},{"date":"2023-11-24","current":-54.558271,"twenty":-8.07291,"median":-3.21274,"eighty":16.355172,"marketCap":3055263184},{"date":"2023-12-01","current":-55.60819,"twenty":-8.887723,"median":-3.353198,"eighty":16.355172,"marketCap":3114058626},{"date":"2023-12-08","current":-56.170646,"twenty":-9.20165,"median":-3.416563,"eighty":16.355172,"marketCap":3145556185},{"date":"2023-12-13","current":-57.820518,"twenty":-9.294121,"median":-3.460856,"eighty":16.355172,"marketCap":3237949024},{"date":"2023-12-22","current":-62.432661,"twenty":-9.507389,"median":-3.497732,"eighty":16.36339,"marketCap":3496229004},{"date":"2024-01-05","current":-59.020425,"twenty":-9.574387,"median":-3.519891,"eighty":16.393525,"marketCap":3305143815},{"date":"2024-01-12","current":-60.445315,"twenty":-9.664756,"median":-3.542049,"eighty":16.393525,"marketCap":3384937630},{"date":"2024-01-19","current":-59.99535,"twenty":-9.712777,"median":-3.553469,"eighty":16.401744,"marketCap":3359739584},{"date":"2024-01-26","current":-58.232986,"twenty":-9.763771,"median":-3.571596,"eighty":16.393525,"marketCap":3261047233},{"date":"2024-02-02","current":-66.888565,"twenty":-9.823019,"median":-3.581378,"eighty":16.393525,"marketCap":3210651139},{"date":"2024-02-09","current":-57.220565,"twenty":-9.869644,"median":-3.59147,"eighty":16.393525,"marketCap":3204351628},{"date":"2024-02-16","current":-57.220565,"twenty":-9.956321,"median":-3.604489,"eighty":16.393525,"marketCap":3204351628},{"date":"2024-02-23","current":-60.89528,"twenty":-10.043591,"median":-3.622011,"eighty":16.393525,"marketCap":3410135677},{"date":"2024-03-01","current":35.936019,"twenty":-10.056469,"median":-3.625758,"eighty":16.447807,"marketCap":3485793844},{"date":"2024-03-08","current":37.18843,"twenty":-10.056469,"median":-3.625758,"eighty":16.567212,"marketCap":3607277745},{"date":"2024-03-15","current":36.961243,"twenty":-10.056469,"median":-3.625758,"eighty":16.670221,"marketCap":3585240545},{"date":"2024-03-22","current":38.523902,"twenty":-10.056469,"median":-3.625758,"eighty":16.766106,"marketCap":3736818537},{"date":"2024-03-28","current":38.306866,"twenty":-10.056469,"median":-3.625758,"eighty":16.809931,"marketCap":3715766038},{"date":"2024-04-05","current":37.156575,"twenty":-10.059306,"median":-3.629041,"eighty":16.978896,"marketCap":3604187794},{"date":"2024-04-12","current":37.894498,"twenty":-10.059306,"median":-3.629041,"eighty":17.16064,"marketCap":3675766290},{"date":"2024-04-19","current":35.007918,"twenty":-10.059306,"median":-3.629041,"eighty":17.258612,"marketCap":3395768056},{"date":"2024-04-26","current":35.44199,"twenty":-10.056469,"median":-3.625758,"eighty":17.840762,"marketCap":3437873054},{"date":"2024-05-03","current":36.498796,"twenty":-10.056469,"median":-3.625758,"eighty":18.170174,"marketCap":3357889189},{"date":"2024-05-10","current":36.511207,"twenty":-10.056469,"median":-3.625758,"eighty":18.755351,"marketCap":3359031034},{"date":"2024-05-17","current":37.541304,"twenty":-10.056469,"median":-3.625758,"eighty":19.13678,"marketCap":3453799934},{"date":"2024-05-24","current":36.396752,"twenty":-10.056469,"median":-3.625758,"eighty":19.228198,"marketCap":3348501156},{"date":"2024-05-31","current":35.595565,"twenty":-10.056469,"median":-3.625758,"eighty":19.551549,"marketCap":3274792011},{"date":"2024-06-07","current":34.863052,"twenty":-10.056469,"median":-3.625758,"eighty":19.788169,"marketCap":3207400793},{"date":"2024-06-14","current":34.496795,"twenty":-10.059306,"median":-3.629041,"eighty":19.972394,"marketCap":3173705183},{"date":"2024-06-21","current":33.832955,"twenty":-10.062143,"median":-3.632324,"eighty":20.117746,"marketCap":3112631892},{"date":"2024-06-28","current":34.061866,"twenty":-10.071657,"median":-3.634664,"eighty":20.170141,"marketCap":3133691648},{"date":"2024-07-05","current":33.398026,"twenty":-10.071657,"median":-3.634664,"eighty":20.359437,"marketCap":3072618356},{"date":"2024-07-12","current":32.779968,"twenty":-10.071657,"median":-3.634664,"eighty":20.997672,"marketCap":3015757016},{"date":"2024-07-15","current":33.466699,"twenty":-10.071657,"median":-3.634664,"eighty":21.055774,"marketCap":3078936283},{"date":"2024-08-02","current":10.070358,"twenty":-10.150883,"median":-3.673418,"eighty":21.36338,"marketCap":3081529526},{"date":"2024-08-09","current":9.455895,"twenty":-10.150883,"median":-3.673418,"eighty":21.36338,"marketCap":2893503995},{"date":"2024-08-16","current":9.763127,"twenty":-10.150883,"median":-3.673418,"eighty":21.36338,"marketCap":2987516760},{"date":"2024-08-23","current":10.179596,"twenty":-10.150883,"median":-3.673418,"eighty":21.36338,"marketCap":3114956286},{"date":"2024-08-30","current":10.309316,"twenty":-10.150883,"median":-3.673418,"eighty":21.36338,"marketCap":3154650565},{"date":"2024-09-06","current":9.742645,"twenty":-10.150883,"median":-3.673418,"eighty":21.36338,"marketCap":2981249243},{"date":"2024-09-13","current":9.408104,"twenty":-10.150883,"median":-3.673418,"eighty":21.36338,"marketCap":2878879787},{"date":"2024-09-20","current":10.718957,"twenty":-10.150883,"median":-3.673418,"eighty":21.101408,"marketCap":3280000919},{"date":"2024-09-27","current":10.084013,"twenty":-10.150883,"median":-3.673418,"eighty":20.560563,"marketCap":3085707871},{"date":"2024-10-04","current":9.585615,"twenty":-10.150883,"median":-3.673418,"eighty":20.205634,"marketCap":2933198274},{"date":"2024-10-11","current":9.756299,"twenty":-10.150883,"median":-3.673418,"eighty":20.146479,"marketCap":2985427588},{"date":"2024-10-18","current":9.626579,"twenty":-10.150883,"median":-3.673418,"eighty":20.146479,"marketCap":2945733309},{"date":"2024-10-25","current":9.462723,"twenty":-10.150883,"median":-3.673418,"eighty":20.138028,"marketCap":2895593168},{"date":"2024-10-31","current":8.714822,"twenty":-10.150883,"median":-3.673418,"eighty":19.647887,"marketCap":2902035670},{"date":"2024-11-08","current":9.117754,"twenty":-10.153746,"median":-3.674208,"eighty":19.166669,"marketCap":3036211945},{"date":"2024-11-15","current":9.111555,"twenty":-10.153746,"median":-3.674208,"eighty":18.78122,"marketCap":3034147899},{"date":"2024-11-22","current":9.099159,"twenty":-10.153746,"median":-3.674208,"eighty":16.930479,"marketCap":3030019806},{"date":"2024-11-29","current":9.638414,"twenty":-10.153746,"median":-3.674208,"eighty":16.766106,"marketCap":3209591825},{"date":"2024-12-06","current":9.756182,"twenty":-10.153746,"median":-3.674208,"eighty":16.574337,"marketCap":3248808703},{"date":"2024-12-13","current":9.53924,"twenty":-10.153746,"median":-3.674208,"eighty":16.377088,"marketCap":3176567086},{"date":"2024-12-20","current":8.968994,"twenty":-10.153746,"median":-3.674208,"eighty":16.1771,"marketCap":2986674836},{"date":"2024-12-27","current":9.334695,"twenty":-10.153746,"median":-3.674208,"eighty":15.960675,"marketCap":3108453562},{"date":"2025-01-03","current":8.541308,"twenty":-10.153746,"median":-3.674208,"eighty":15.74151,"marketCap":2844255649},{"date":"2025-01-10","current":8.398747,"twenty":-10.15661,"median":-3.674999,"eighty":15.187166,"marketCap":2796782587},{"date":"2025-01-17","current":8.429738,"twenty":-10.15661,"median":-3.674999,"eighty":14.123802,"marketCap":2807102818},{"date":"2025-01-24","current":8.541308,"twenty":-10.15661,"median":-3.674999,"eighty":12.229294,"marketCap":2844255649},{"date":"2025-01-31","current":8.355358,"twenty":-10.15661,"median":-3.674999,"eighty":11.774076,"marketCap":2782334264},{"date":"2025-02-07","current":8.175606,"twenty":-10.15661,"median":-3.674999,"eighty":11.669683,"marketCap":2722476924},{"date":"2025-02-14","current":7.915276,"twenty":-10.15661,"median":-3.674999,"eighty":11.541332,"marketCap":2635786984},{"date":"2025-02-21","current":12.449378,"twenty":-10.15661,"median":-3.674999,"eighty":11.52593,"marketCap":2639268117},{"date":"2025-02-28","current":11.712888,"twenty":-10.15661,"median":-3.674999,"eighty":11.52593,"marketCap":2483132177},{"date":"2025-03-07","current":11.32214,"twenty":-10.159473,"median":-3.675279,"eighty":11.440344,"marketCap":2400293756},{"date":"2025-03-14","current":10.388159,"twenty":-10.159473,"median":-3.675279,"eighty":11.489992,"marketCap":2202289726},{"date":"2025-03-21","current":11.045758,"twenty":-10.159473,"median":-3.675279,"eighty":11.489992,"marketCap":2341700727},{"date":"2025-03-28","current":10.62642,"twenty":-10.159473,"median":-3.675279,"eighty":11.489992,"marketCap":2252800958},{"date":"2025-04-04","current":9.263569,"twenty":-10.159473,"median":-3.675279,"eighty":11.489992,"marketCap":1963876709},{"date":"2025-04-11","current":8.979147,"twenty":-10.15661,"median":-3.674999,"eighty":11.484858,"marketCap":1903579170},{"date":"2025-04-17","current":9.09341,"twenty":-10.15661,"median":-3.674999,"eighty":11.484858,"marketCap":1927802871},{"date":"2025-04-25","current":9.512373,"twenty":-10.159473,"median":-3.675279,"eighty":11.489992,"marketCap":2016623108},{"date":"2025-05-02","current":9.559983,"twenty":-10.159473,"median":-3.675279,"eighty":11.489992,"marketCap":2026716317},{"date":"2025-05-09","current":16.384875,"twenty":-10.159473,"median":-3.675279,"eighty":11.531064,"marketCap":2080879082},{"date":"2025-05-16","current":17.045936,"twenty":-10.159473,"median":-3.674208,"eighty":11.65257,"marketCap":2164833858},{"date":"2025-05-23","current":16.148781,"twenty":-10.159473,"median":-3.6534,"eighty":11.72393,"marketCap":2050895233},{"date":"2025-05-30","current":16.510791,"twenty":-10.159473,"median":-3.629041,"eighty":11.766258,"marketCap":2096870468},{"date":"2025-06-06","current":15.771032,"twenty":-10.159473,"median":-3.604398,"eighty":11.937378,"marketCap":2002921076},{"date":"2025-06-13","current":16.447833,"twenty":-10.159473,"median":-3.588007,"eighty":12.388042,"marketCap":2088874775},{"date":"2025-06-20","current":16.038604,"twenty":-10.162337,"median":-3.578159,"eighty":15.511387,"marketCap":2036902771},{"date":"2025-06-27","current":16.55801,"twenty":-10.162337,"median":-3.568226,"eighty":15.739397,"marketCap":2102867237},{"date":"2025-07-03","current":17.061675,"twenty":-10.162337,"median":-3.549185,"eighty":15.841236,"marketCap":2166832781},{"date":"2025-07-11","current":17.848653,"twenty":-10.162337,"median":-3.540618,"eighty":16.000829,"marketCap":2266778942},{"date":"2025-07-18","current":16.998717,"twenty":-10.162337,"median":-3.507581,"eighty":16.081216,"marketCap":2158837088},{"date":"2025-07-25","current":17.518122,"twenty":-10.162337,"median":-3.495637,"eighty":16.142485,"marketCap":2224801554},{"date":"2025-08-01","current":36.742661,"twenty":-10.162337,"median":-3.456698,"eighty":16.1771,"marketCap":2131074349},{"date":"2025-08-08","current":35.570815,"twenty":-10.162337,"median":-3.417502,"eighty":16.307701,"marketCap":2063107278},{"date":"2025-08-15","current":38.224839,"twenty":-10.162337,"median":-3.417502,"eighty":16.351669,"marketCap":2217040670},{"date":"2025-08-22","current":38.500582,"twenty":-10.162337,"median":-3.417502,"eighty":16.434619,"marketCap":2233033750},{"date":"2025-08-29","current":40.534185,"twenty":-10.162337,"median":-3.417502,"eighty":16.560113,"marketCap":2350982712},{"date":"2025-09-05","current":41.740559,"twenty":-10.1652,"median":-3.433,"eighty":16.629128,"marketCap":2420952436},{"date":"2025-09-12","current":41.361413,"twenty":-10.162337,"median":-3.417502,"eighty":16.709109,"marketCap":2398961952},{"date":"2025-09-19","current":41.809495,"twenty":-10.162337,"median":-3.417502,"eighty":16.776195,"marketCap":2424950706},{"date":"2025-09-26","current":38.914196,"twenty":-10.162337,"median":-3.417502,"eighty":16.947295,"marketCap":2257023369},{"date":"2025-10-03","current":38.224839,"twenty":-10.162337,"median":-3.417502,"eighty":17.03964,"marketCap":2217040670},{"date":"2025-10-10","current":37.052932,"twenty":-10.162337,"median":-3.417502,"eighty":17.090583,"marketCap":2149070082},{"date":"2025-10-17","current":37.501014,"twenty":-10.162337,"median":-3.417502,"eighty":17.354431,"marketCap":2175058836},{"date":"2025-10-24","current":38.466114,"twenty":-10.162337,"median":-3.417502,"eighty":17.59682,"marketCap":2231034615},{"date":"2025-10-31","current":-178.753982,"twenty":-10.172486,"median":-3.448497,"eighty":17.810878,"marketCap":2145047787},{"date":"2025-11-07","current":-169.247209,"twenty":-10.219605,"median":-3.476395,"eighty":17.810878,"marketCap":2030966504},{"date":"2025-11-14","current":-174.244666,"twenty":-10.301936,"median":-3.504298,"eighty":17.810878,"marketCap":2090935987},{"date":"2025-11-21","current":-163.916588,"twenty":-10.6072,"median":-3.538772,"eighty":17.810878,"marketCap":1966999055},{"date":"2025-11-28","current":-180.408196,"twenty":-10.799451,"median":-3.540618,"eighty":17.810878,"marketCap":2164898350},{"date":"2025-12-05","current":-174.577829,"twenty":-11.1402,"median":-3.542049,"eighty":17.810878,"marketCap":2094933953},{"date":"2025-12-12","current":-179.90845,"twenty":-11.860354,"median":-3.542049,"eighty":17.810878,"marketCap":2158901402},{"date":"2025-12-19","current":-180.574778,"twenty":-12.666412,"median":-3.542049,"eighty":17.810878,"marketCap":2166897333},{"date":"2025-12-26","current":-181.074523,"twenty":-12.945597,"median":-3.542049,"eighty":17.810878,"marketCap":2172894281},{"date":"2026-01-02","current":-174.244666,"twenty":-13.160355,"median":-3.542049,"eighty":17.810878,"marketCap":2090935987},{"date":"2026-01-09","current":-185.738817,"twenty":-13.430949,"median":-3.542049,"eighty":17.810878,"marketCap":2228865799},{"date":"2026-01-16","current":-191.402601,"twenty":-13.900553,"median":-3.542049,"eighty":17.810878,"marketCap":2296831214},{"date":"2026-01-23","current":-193.06842,"twenty":-36.411218,"median":-3.542049,"eighty":17.810878,"marketCap":2316821042},{"date":"2026-01-30","current":-181.574269,"twenty":-42.996332,"median":-3.544901,"eighty":17.810878,"marketCap":2178891230},{"date":"2026-02-06","current":-186.07198,"twenty":-44.121622,"median":-3.546973,"eighty":17.810878,"marketCap":2232863765},{"date":"2026-02-13","current":-190.236528,"twenty":-45.253331,"median":-3.546973,"eighty":17.810878,"marketCap":2282838334},{"date":"2026-02-20","current":-190.236528,"twenty":-46.332575,"median":-3.546973,"eighty":17.810878,"marketCap":2282838334},{"date":"2026-02-27","current":-8.333483,"twenty":-46.332575,"median":-3.566587,"eighty":17.810878,"marketCap":2358375720},{"date":"2026-03-06","current":-8.041704,"twenty":-46.332575,"median":-3.581442,"eighty":17.810878,"marketCap":2275802360},{"date":"2026-03-13","current":-7.379865,"twenty":-46.332575,"median":-3.589648,"eighty":17.810878,"marketCap":2088501812},{"date":"2026-03-20","current":-7.481341,"twenty":-46.332575,"median":-3.589648,"eighty":17.810878,"marketCap":2117219505},{"date":"2026-03-27","current":-7.623572,"twenty":-46.332575,"median":-3.632324,"eighty":17.810878,"marketCap":2157470827},{"date":"2026-04-02","current":-7.381779,"twenty":-46.332575,"median":-3.670075,"eighty":17.810878,"marketCap":2089043580},{"date":"2026-04-10","current":-7.950703,"twenty":-46.332575,"median":-4.395912,"eighty":17.810878,"marketCap":2250048866},{"date":"2026-04-17","current":-7.950703,"twenty":-46.332575,"median":-4.654495,"eighty":17.810878,"marketCap":2250048866},{"date":"2026-04-24","current":-7.872476,"twenty":-46.332575,"median":-4.7273,"eighty":17.810878,"marketCap":2227910639},{"date":"2026-05-01","current":-10.736806,"twenty":-46.332575,"median":-4.787552,"eighty":17.810878,"marketCap":2308413282},{"date":"2026-05-08","current":-10.480181,"twenty":-46.332575,"median":-4.837762,"eighty":17.810878,"marketCap":2253238933},{"date":"2026-05-15","current":-10.208577,"twenty":-46.332575,"median":-4.837762,"eighty":17.810878,"marketCap":2194844001},{"date":"2026-05-22","current":-10.733054,"twenty":-46.332575,"median":-4.837762,"eighty":17.810878,"marketCap":2307606629},{"date":"2026-05-29","current":-11.398016,"twenty":-46.392533,"median":-4.816423,"eighty":17.848653,"marketCap":2450573531},{"date":"2026-06-05","current":-13.149396,"twenty":-46.332575,"median":-4.837762,"eighty":17.810878,"marketCap":2827120163},{"date":"2026-06-12","current":-13.449097,"twenty":-46.332575,"median":-4.837762,"eighty":17.810878,"marketCap":2891555950},{"date":"2026-06-18","current":-13.580217,"twenty":-46.332575,"median":-4.837762,"eighty":17.810878,"marketCap":2919746607},{"date":"2026-06-26","current":-13.645776,"twenty":-46.392533,"median":-4.816423,"eighty":17.848653,"marketCap":2933841935},{"date":"2026-07-02","current":-13.27115,"twenty":-46.392533,"median":-4.816423,"eighty":17.848653,"marketCap":2853297201},{"date":"2026-07-10","current":-13.243053,"twenty":-46.392533,"median":-5.159038,"eighty":17.848653,"marketCap":2847256346},{"date":"2026-07-17","current":-13.673873,"twenty":-46.392533,"median":-5.361788,"eighty":17.848653,"marketCap":2939882791},{"date":"2026-07-24","current":-13.664508,"twenty":-46.392533,"median":-5.472783,"eighty":17.848653,"marketCap":2937869172},{"date":"2026-07-31","current":-14.104694,"twenty":-46.400028,"median":-5.505341,"eighty":17.858097,"marketCap":3032509235},{"date":"2026-08-07","current":-17.727254,"twenty":-46.400028,"median":-5.52902,"eighty":17.858097,"marketCap":2889542332},{"date":"2026-08-14","current":-18.565123,"twenty":-46.400028,"median":-5.558619,"eighty":17.858097,"marketCap":3026115099},{"date":"2026-08-21","current":-19.540935,"twenty":-46.400028,"median":-5.614856,"eighty":17.858097,"marketCap":3185172380},{"date":"2026-08-28","current":-19.405062,"twenty":-46.400028,"median":-5.644455,"eighty":17.858097,"marketCap":3163025164},{"date":"2026-09-04","current":-18.626884,"twenty":-46.400028,"median":-5.662214,"eighty":17.858097,"marketCap":3036182016},{"date":"2026-09-11","current":-18.923333,"twenty":-46.400028,"median":-5.688853,"eighty":17.858097,"marketCap":3084503215},{"date":"2026-09-18","current":-18.602179,"twenty":-46.400028,"median":-5.718451,"eighty":17.858097,"marketCap":3032155249},{"date":"2026-09-25","current":-18.78746,"twenty":-46.400028,"median":-5.721411,"eighty":17.858097,"marketCap":3062355999},{"date":"2026-10-02","current":-19.046853,"twenty":-46.400028,"median":-5.721411,"eighty":17.858097,"marketCap":3104637048},{"date":"2026-10-08","current":-18.775108,"twenty":-46.400028,"median":-6.205152,"eighty":17.858097,"marketCap":3060342616}],"updateTime":1791548207116},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PK\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673071460","title":"Cullinan Therapeutics Announces First Patient Dosed in Planned Registrational Phase 2 Study of CLN-049 in Relapsed/Refractory Acute Myeloid Leukemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2673071460","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673071460?lang=en_us&edition=fundamental","pubTime":"2026-10-08 19:00","pubTimestamp":1791457200,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Oct.  08, 2026 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a clinical-stage biopharmaceutical company accelerating potential first- or best-in-class, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/08/3377131/0/en/cullinan-therapeutics-announces-first-patient-dosed-in-planned-registrational-phase-2-study-of-cln-049-in-relapsed-refractory-acute-myeloid-leukemia.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KBWY","BK4218","BK4181","PK","CGEM","BK4139","LU1169590202.USD","PD","BK4023","LU1169589451.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673605673","title":"Hilton Names Jeff Moore Executive Vice President, Chief Technology Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2673605673","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673605673?lang=en_us&edition=fundamental","pubTime":"2026-10-06 20:20","pubTimestamp":1791289246,"startTime":"0","endTime":"0","summary":"Hilton names Jeff Moore executive vice president, chief technology officerHilton named Jeff Moore executive vice president, chief technology officer, effective Oct. 26.Moore joins from Uber, where he ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDL6MYFXz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KBWY","PK","BK4218","BK4181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673737081","title":"Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504","url":"https://stock-news.laohu8.com/highlight/detail?id=2673737081","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673737081?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:05","pubTimestamp":1791230700,"startTime":"0","endTime":"0","summary":"On track to initiate dosing by early November 2026; topline Phase 1 proof-of-mechanism data anticipated approximately six months following study initiation Randomized, double-blind, placebo-controlled","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/05/3374999/0/en/equillium-receives-australian-regulatory-clearance-to-initiate-first-in-human-clinical-trial-of-eq504.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1169589451.USD","LU1169590202.USD","BK4218","KBWY","BK4023","PK","PD","BK4181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673702771","title":"Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly","url":"https://stock-news.laohu8.com/highlight/detail?id=2673702771","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673702771?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:00","pubTimestamp":1791201600,"startTime":"0","endTime":"0","summary":"Trial follows promising MAR002 Phase 1 clinical trial results that demonstrated deep and durable IGF-1 suppression with PK properties that may enable dosing as infrequently as once every two weeks, co","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/05/3374474/18623/en/marea-therapeutics-a-subsidiary-of-lisata-therapeutics-announces-first-patient-dosed-in-phase-2-clinical-trial-of-mar002-a-potential-best-in-disease-investigational-therapy-for-the.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4535","ENDO","BK4551","KBWY","GNOM","PTH","LU0889565916.HKD","LU0320765992.SGD","PK","BK4585","GH","BK4007","EKG","HELX","LENZ","FFOX","BK4588","BK4196","LFSC","LU0109394709.USD","BK4218","BK4181","BK4183","GNMX","GDOC","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672944717","title":"Climb Bio to Present New Data at American Society of Nephrology (ASN) Kidney Week 2026 for CLYM116 and Budoprutug","url":"https://stock-news.laohu8.com/highlight/detail?id=2672944717","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672944717?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:30","pubTimestamp":1790947800,"startTime":"0","endTime":"0","summary":"Preliminary Phase 2 data from the ongoing PrisMN study of budoprutug in primary membranous nephropathy selected for oral presentation Presentations on CLYM116 and budoprutug programs highlight advance","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/02/3373844/0/en/climb-bio-to-present-new-data-at-american-society-of-nephrology-asn-kidney-week-2026-for-clym116-and-budoprutug.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJTD4V19.USD","LU0795875169.SGD","IE00B7KXQ091.USD","LU1244550494.USD","SLE","IE00BJJMRX11.SGD","IE00BJJMRY28.SGD","LU1244550221.USD","LU1430594728.SGD","IE0004445015.USD","BK4209","LU1732800096.USD","BK4610","LU0795875086.SGD","BK4117","ITP","LU1732799900.SGD","LU0726765562.USD","BK4566","MCD","BK4585","LU1585245621.USD","BK4588","BK4107","BK4581","PD","LU0942090050.USD","LU0868494708.USD","LU0417517546.SGD","LU1035773651.USD","BK4181","LU0868494617.USD","LU1169590202.USD","PK","AFG","BK4534","LU1069347547.HKD","LU0256863811.USD","BK4199","BK4218","BK4139","LU2347655156.SGD","BK4550","LU1074936037.SGD","BK4504","LU1169589451.USD","BK4023","LU2347655073.USD","KBWY","PMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672776366","title":"Park Hotels & Resorts (PK) Could Be 25% Undervalued On Its Debt Refinance","url":"https://stock-news.laohu8.com/highlight/detail?id=2672776366","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672776366?lang=en_us&edition=fundamental","pubTime":"2026-10-01 22:20","pubTimestamp":1790864429,"startTime":"0","endTime":"0","summary":"Park Hotels & Resorts (PK) just wiped out a major financing overhang by repaying a US$1.275b CMBS loan tied to Hilton Hawaiian Village and extending its overall debt maturity profile in the process.\nThat refinancing move comes amid a strong run in Park Hotels & Resorts’ stock, with the share price at US$15.42 after a small 1-day decline of 0.96%. The year-to-date share price return of 43.18% and 1-year total shareholder return of 51.58% point to momentum that has been building rather than...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9621070-choice2-card/1789036122243","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9621070-choice2-card/1789036122243"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-pk/park-hotels-resorts/news/park-hotels-resorts-pk-could-be-25-undervalued-on-its-debt-r","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-pk/park-hotels-resorts/news/park-hotels-resorts-pk-could-be-25-undervalued-on-its-debt-r","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4218","BK4181","KBWY","PK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672377759","title":"Agomab Reports Positive Topline Data from STENOVA Open-Label Extension Study of Ontunisertib in Fibrostenosing Crohn's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2672377759","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672377759?lang=en_us&edition=fundamental","pubTime":"2026-10-01 18:30","pubTimestamp":1790850600,"startTime":"0","endTime":"0","summary":"--Favorable safety and tolerability profile maintained through up to 60 weeks of treatment with ontunisertib in Fibrostenosing Crohn’s disease (FSCD) patients -- -- Low annualized FSCD-related event r","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/01/3372696/0/en/agomab-reports-positive-topline-data-from-stenova-open-label-extension-study-of-ontunisertib-in-fibrostenosing-crohn-s-disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PK","BK4181","BK4218","KBWY","BID"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672782608","title":"Park Hotels & Resorts Repays USD 1.28 Billion Hilton Hawaiian Village Mortgage Loan","url":"https://stock-news.laohu8.com/highlight/detail?id=2672782608","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672782608?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:15","pubTimestamp":1790799325,"startTime":"0","endTime":"0","summary":"Park Hotels & Resorts repays USD 1.28 billion Hilton Hawaiian Village mortgage loanPark Hotels repaid the USD 1.275 billion CMBS loan secured by the Hilton Hawaiian Village Waikiki Beach Resort.Repaym","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDLcN7S9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4218","PK","KBWY","BK4181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672782640","title":"Park Hotels & Resorts - Extends Weighted-Average Debt Maturity to 3.1 Years; Less than 11% Debt Matures Through 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2672782640","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672782640?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:15","pubTimestamp":1790799301,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nTUABBLVWW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KBWY","PEJ","LU2764263203.CNY","LU2506952170.USD","LU0823417737.USD","LU0170899867.USD","PK","LU1366192091.USD","LU0823411888.USD","BK4588","BK4585","HLT","LU0823417653.USD","LU2764263039.SGD","LU2720916845.USD","BK4142","LU2506952097.USD","LU0154245756.USD","LU2506951958.HKD","BK4566","LU0061475181.USD","LU0950375773.USD","BK4218","LU0154245673.USD","BK4181","LU2506951875.HKD","LU2764262908.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672778264","title":"Park Hotels & Resorts - Repayment Funded by $700 Mln Bonnet Creek Mortgage and $600 Mln Term Loan Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2672778264","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672778264?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:15","pubTimestamp":1790799301,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nTUABBLVWW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2720916845.USD","PK","HLT","LU2506951875.HKD","LU0823411888.USD","LU2506951958.HKD","LU2764263039.SGD","LU0950375773.USD","LU0823417737.USD","LU0154245673.USD","LU2506952170.USD","LU2506952097.USD","BK4142","BK4218","BK4566","LU0061475181.USD","BK4588","LU2764263203.CNY","BK4181","LU0154245756.USD","LU1366192091.USD","LU0823417653.USD","LU0170899867.USD","BK4585","KBWY","LU2764262908.HKD","PEJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671320189","title":"Press Release: Avacta Group Plc: Interim Results for the Six Months to June 30, 2026, and Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2671320189","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671320189?lang=en_us&edition=fundamental","pubTime":"2026-09-30 20:00","pubTimestamp":1790769600,"startTime":"0","endTime":"0","summary":"LONDON and PHILADELPHIA, Sept. 30, 2026  -- Avacta Therapeutics , a life sciences company developing innovative, targeted oncology drugs, today publishes its unaudited interim results for the six months ended June 30, 2026 .H1 highlights and post periodResearch & developmentNext Generation pre|CISION pipeline-- AVA6103 . -- Preliminary preclinical and clinical data with AVA6103 have been. presented recently. Data reported in the Phase 1a trial in. patients with select solid tumors demonstrate proof of mechanism. demonstrates a clean safety profile through the first three. dose levels, including a payload dose level 50% higher than. -- The comparison of the preclinical modeled pharmacokinetic.  data and clinical trial PK data demonstrates an. exceptional alignment through the first 3 dose levels with. controlled release of exatecan evident in patients for days. -- The first head-to-head preclinical comparison of AVA6103 and. Enhertu, a marketed antibody drug conjugate  that targets. HER","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4231","BK4585","IE00BFXG0V08.USD","IE00B5TLWC47.USD","LU2413666699.HKD","LU1093756325.SGD","IE00BYQQ9H92.USD","BK4588","LU2211817866.USD","LU2413666426.HKD","LU0347712357.USD","KBWY","R","BK4232","BK4121","ADC","LU1721428933.USD","BK4181","LU1093756168.USD","BK4123","IND","BK4218","PK","BK4533","MTD","NETL","BK4080","BK4567","AVCTF","PDC","BK4022","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671214412","title":"Propanc Biopharma Provides Corporate Update & Year-End June 30, 2025-26, Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2671214412","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671214412?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:30","pubTimestamp":1790685000,"startTime":"0","endTime":"0","summary":"Plans To Commence World-First Phase 1b First-In-Human (FIH) Study of PRP Q1, 2027MELBOURNE, Australia, Sept.  29, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/29/3370837/0/en/propanc-biopharma-provides-corporate-update-year-end-june-30-2025-26-financial-results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1169589451.USD","PD","KBWY","BK4181","LU1169590202.USD","CDMO","PDX","BK4139","PK","BK4023","BK4218"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671211934","title":"Nasus Pharma Announces Enrollment and Dosing of First Patient in Phase 1 Study of NS003 Intranasal Formulation of Ondansetron","url":"https://stock-news.laohu8.com/highlight/detail?id=2671211934","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671211934?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:00","pubTimestamp":1790683200,"startTime":"0","endTime":"0","summary":"Topline Data from First-in-Human Pharmacokinetic Study Anticipated in the Fourth Quarter of 2026TEL AVIV, Israel, Sept.  29, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd.(NYSE: NSRX) (“Nasus Pharma” or t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/29/3370749/0/en/nasus-pharma-announces-enrollment-and-dosing-of-first-patient-in-phase-1-study-of-ns003-intranasal-formulation-of-ondansetron.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4218","CINV","BK4007","KBWY","BK4181","BK4123","AUC","PK","NSRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670280859","title":"M Core Acquires Newcastle Leisure Complex the Gate","url":"https://stock-news.laohu8.com/highlight/detail?id=2670280859","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670280859?lang=en_us&edition=fundamental","pubTime":"2026-09-28 16:31","pubTimestamp":1790584268,"startTime":"0","endTime":"0","summary":"M Core acquires Newcastle leisure complex The GateM Core completed the acquisition of The Gate, a 235,288-sq-ft leisure destination in central Newcastle, on Sept. 28, 2026.Sheet Anchor Evolve, part of","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL7Ps25b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KBWY","BK4181","BK4218","PK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670840282","title":"Park Hotels & Resorts Inc : Raymond James Raises to Strong Buy from Market Perform","url":"https://stock-news.laohu8.com/highlight/detail?id=2670840282","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670840282?lang=en_us&edition=fundamental","pubTime":"2026-09-28 15:33","pubTimestamp":1790580797,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nFWN45K08F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PK","BK4181","BK4218","KBWY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670482204","title":"Avacta Group plc: The FOCUS-01 Clinical Trial Design and Preclinical Data Further Demonstrate the Potential of AVA6103 at AACR Conference on Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2670482204","media":"GlobeNewswire","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670482204?lang=en_us&edition=fundamental","pubTime":"2026-09-25 14:00","pubTimestamp":1790316000,"startTime":"0","endTime":"0","summary":"LONDON and PHILADELPHIA, Sept.  25, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, the \"Company\", \"Avacta\"), a life sciences company developing innovative, targeted oncology drugs, today ann","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/25/3368853/0/en/avacta-group-plc-the-focus-01-clinical-trial-design-and-preclinical-data-further-demonstrate-the-potential-of-ava6103-at-aacr-conference-on-pancreatic-cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0828238088.HKD","MTD","BK4108","BK4509","LU1023057109.AUD","IE00B5TLWC47.USD","BK4585","LU0347712357.USD","NETL","BK4218","BK4565","BK4548","LU2211817866.USD","BK4588","BK4123","BK4571","IE00BYQNZ168.SGD","BK4567","IE00BYQQ9H92.USD","BK4533","BK4526","LU0269904917.USD","BK4121","PDX","BK4181","LU0359202008.SGD","IE00BFXG0V08.USD","KBWY","LU2413666699.HKD","LU0359201612.USD","LU2039709279.SGD","ADC","BK4552","IE00B12V2V27.USD","LU0456842615.SGD","PDC","LU0509642566.USD","LU1721428933.USD","PK","TME","BK4531","BK4563","LU2413666426.HKD","BK4080","BK4231","01698","IE00BYTNYN87.SGD","SG9999011746.SGD","LU1093756168.USD","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667984870","title":"Avacta Achieves Clinical Proof of Mechanism for the Next Generation of pre|CISION® Medicines with AVA6103 (FAP-Exd) in the Phase 1 FOCUS-01 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2667984870","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667984870?lang=en_us&edition=fundamental","pubTime":"2026-09-16 23:00","pubTimestamp":1789570800,"startTime":"0","endTime":"0","summary":"LONDON and PHILADELPHIA, Sept.  16, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs, announces today that it has achiev","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/16/3363359/0/en/avacta-achieves-clinical-proof-of-mechanism-for-the-next-generation-of-pre-cision-medicines-with-ava6103-fap-exd-in-the-phase-1-focus-01-trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1721428933.USD","BK4123","BK4181","BK4567","BK4218","IE00BFXG0V08.USD","LU1169589451.USD","LU1093756325.SGD","LU1093756168.USD","BK4121","IE00B5TLWC47.USD","ADC","LU0347712357.USD","BK4023","PD","PDC","BK4080","LU1169590202.USD","BK4585","LU2413666699.HKD","LU2413666426.HKD","BK4231","BK4548","PK","BK4588","IE00BYQQ9H92.USD","LU2211817866.USD","MDCO","BK4533","KBWY","MTD","NETL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667761836","title":"Truist Financial Sticks to Its Hold Rating for Park Hotels & Resorts (PK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667761836","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667761836?lang=en_us&edition=fundamental","pubTime":"2026-09-15 10:25","pubTimestamp":1789439128,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Patrick Scholes from Truist Financial maintained a Hold rating on Park Hotels & Resorts, with a price target of $17...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/truist-financial-sticks-to-its-hold-rating-for-park-hotels-resorts-pk-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/truist-financial-sticks-to-its-hold-rating-for-park-hotels-resorts-pk-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667696238","title":"Agomab Announces Positive Phase 1 Results for AGMB-447 in Patients with Idiopathic Pulmonary Fibrosis and Design of Phase 2 INSPIRIA Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2667696238","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667696238?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:05","pubTimestamp":1789416300,"startTime":"0","endTime":"0","summary":"--Topline Phase 1 data shows generally favorable safety and tolerability profile of AGMB-447 -- -- Pharmacokinetic profile confirms efficient lung restriction with low systemic exposure and high expos","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/14/3361543/0/en/agomab-announces-positive-phase-1-results-for-agmb-447-in-patients-with-idiopathic-pulmonary-fibrosis-and-design-of-phase-2-inspiria-study.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PK","BK4181","AGMB","BK4218","CTA","BAL","BK4007","KBWY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667769623","title":"Sionna Therapeutics Announces Plans to Advance SION-451 + SION-2222 Dual Combination into Phase 2a Proof-of-Concept Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2667769623","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667769623?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:01","pubTimestamp":1789416060,"startTime":"0","endTime":"0","summary":"Post hoc analyses of SION-719 PreciSION CF subset showed a mean placebo-adjusted sweat chloride reduction of up to -8.6 mmol/L consistent with NBD1 biological activity Dual combination Phase 2a trial ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/14/3361527/0/en/sionna-therapeutics-announces-plans-to-advance-sion-451-sion-2222-dual-combination-into-phase-2a-proof-of-concept-trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KBWY","LU0630314457.HKD","SION","BID","CF","LU0345780950.USD","BK4585","LU0345781412.USD","VEGI","BK4139","BK4218","BK4093","PK","BK4181","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":1,"totalSize":153,"code":"91000000","status":"200"}]}}